BEL Stock Rises 5% as Order Inflow Optimism Keeps MOFSL Upbeat Post-Q2

BEL’s Rally Turns Attention to Earnings and Pending Defence Orders

Strong quarterly growth and optimism about future orders lifted the shares, but delays in large defence projects remain a key watchpoint.

Earnings strength supported the move

BEL shares rose for a third consecutive trading session, touching an intraday high of ₹396.95 after opening at ₹381.90 on the NSE. By 1:20 PM, the stock was up 4.4% at ₹396.70, with around 16 million shares traded on the exchange. It had advanced nearly 7% over the three sessions. The Nifty 50 was up 0.38% at the same time, while BEL was among the leading gainers on the benchmark indices.

The move reflected both broad buying in defence shares and a positive response to BEL’s Q2 results. Motilal Oswal said the company exceeded its estimates for revenue, EBITDA and profit after tax. Revenue rose 26% year on year to ₹73 billion, EBITDA increased 20% to ₹20.4 billion and profit after tax grew 20% to ₹15.4 billion.

Margin contraction tempers the headline growth

The quarter’s growth was not uniform across every measure. EBITDA margin contracted by 140 basis points year on year to 28%, even as absolute EBITDA rose. For investors, that distinction matters: revenue and profit growth show business momentum, while margin movement indicates how much operating profit the company retains from each unit of revenue.

The results therefore offer support to the near-term earnings narrative, but the margin decline is a factor to track alongside future growth. The supplied brokerage commentary does not identify the reason for the contraction, so it would be premature to attribute it to a specific cost or product mix.

A large order book, with major awards still pending

BEL’s order book stood at ₹687 billion at the end of Q2FY27, with 90% linked to defence programmes and the remainder from non-defence businesses. The company received ₹38 billion of orders during the quarter. That backlog provides visibility, but the pace at which it converts into fresh orders and eventually revenue remains important to the growth outlook.

Motilal Oswal noted that base order inflows fell 31% year on year, as ordering from the Ministry of Defence has yet to ramp up meaningfully. A QRSAM order worth ₹300 billion has been delayed, with BEL hoping for progress at the next CCS meeting. The company is also hopeful of a ₹200 billion order for next-generation corvettes. These are potential awards, not confirmed additions to the order book; delays in project finalisation could defer the expected inflow.

Brokerage outlook rests on execution as well as inflows

Motilal Oswal retained its Buy rating and raised its target price to ₹540 from ₹530, while maintaining its estimates. It expects revenue, EBITDA and profit after tax to grow at compound annual rates of 15%, 14% and 15%, respectively, over FY26-29. Those projections depend in part on order inflows gathering pace, making the timing of large government projects a material variable.

The brokerage’s identified risks include slower orders in defence and non-defence businesses, stronger competition, further delays in large tenders, a sharp rise in commodity prices and delayed payments from the Ministry of Defence. The revised target signals the brokerage’s positive view, but it does not remove those execution and timing risks.

Key Highlights

• BEL rose nearly 5% intraday and was up nearly 7% over three trading sessions.
• Q2 revenue increased 26% year on year to ₹73 billion; PAT rose 20% to ₹15.4 billion.
• EBITDA grew 20% to ₹20.4 billion, while margin narrowed 140 basis points to 28%.
• The order book was ₹687 billion, but quarterly order inflows were ₹38 billion.
• MOFSL raised its target price to ₹540 and flagged delays, competition and cost risks.

Investor Note: BEL’s results and order backlog support the growth case, but investors may want to distinguish confirmed orders from awards still awaiting approval and monitor margins alongside order inflows. The brokerage target is an opinion, not a guaranteed outcome.